KLK6 and neoplasm: In further exploring the biological characteristics of EPCs, we conducted HALLMARK pathway enrichment analysis (Fig. 6A) and found that CASC15+KLK6+EPC scored significantly higher than other subpopulations across most tumor progression-related pathways, suggesting that this subpopulation has higher malignant potential.